EAM
GH icon

Eventide Asset Management’s Guardant Health GH Stock Holding History

Eventide Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294M Sell
1,957,828
-404,551
-17% -$44M 3.93% 1
2026
Q1 		$218M Sell
2,362,379
-148,712
-6% -$14.9M 3.61% 1
2025
Q4 		$256M Sell
2,511,091
-810,247
-24% -$72.5M 4.01% 1
2025
Q3 		$208M Sell
3,321,338
-137,625
-4% -$7.49M 3.41% 1
2025
Q2 		$180M Sell
3,458,963
-107,775
-3% -$4.81M 3.15% 2
2025
Q1 		$152M Sell
3,566,738
-241,199
-6% -$10.4M 3.03% 2
2024
Q4 		$116M Sell
3,807,937
-29,363
-0.8% -$826K 2.12% 4
2024
Q3 		$88M Buy
3,837,300
+76,762
+2% +$2.17M 1.52% 14
2024
Q2 		$109M Sell
3,760,538
-418,894
-10% -$9.75M 1.86% 11
2024
Q1 		$86.2M Buy
4,179,432
+291,286
+7% +$6.24M 1.35% 21
2023
Q4 		$105M Buy
3,888,146
+298,616
+8% +$7.83M 1.72% 13
2023
Q3 		$106M Sell
3,589,530
-419,072
-10% -$14.7M 1.91% 12
2023
Q2 		$144M Buy
4,008,602
+2,133,582
+114% +$61.3M 2.43% 7
2023
Q1 		$44M Buy
1,875,020
+194,020
+12% +$5.54M 0.81% 43
2022
Q4 		$45.7M Hold
1,681,000
– – 0.9% 39
2022
Q3 		$90.5M Hold
1,681,000
– – 1.78% 19
2022
Q2 		$67.8M Buy
1,681,000
+368,100
+28% +$18.2M 1.45% 22
2022
Q1 		$87M Buy
1,312,900
+426,800
+48% +$29.2M 1.36% 29
2021
Q4 		$88.6M Buy
886,100
+708,100
+398% +$73.2M 1.13% 32
2021
Q3 		$22.3M Buy
+178,000
New +$21.1M 0.29% 90

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Eventide Asset Management's GH Position: Q2 2026 in Review

Eventide Asset Management reduced its Guardant Health (GH) stake by 17% in Q2 2026, selling an estimated $44M and leaving 1,957,828 shares worth $294M. The position accounts for 3.93% of the portfolio, ranked #1.

Eventide Asset Management first reported a position in GH in Q3 2021 and has held it in 20 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Eventide Asset Management held 1,957,828 shares of Guardant Health worth $294M as of Q2 2026.
  • Eventide Asset Management sold 404,551 Guardant Health shares in Q2 2026, an estimated $44M.
  • Guardant Health made up 3.93% of Eventide Asset Management's portfolio in Q2 2026, its #1 holding.
  • Eventide Asset Management first reported a position in Guardant Health in Q3 2021 and has held it in 20 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.